{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:21:57Z","timestamp":1791328917687,"version":"4.3.1"},"reference-count":239,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4,1]]},"DOI":"10.1210\/er.2007-0030","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T17:23:04Z","timestamp":1207243384000},"page":"133-154","source":"Crossref","is-referenced-by-count":157,"title":["A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function"],"prefix":"10.1210","volume":"29","author":[{"given":"John M. C.","family":"Connell","sequence":"first","affiliation":[{"name":"Medical Research Council Blood Pressure Group, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"MacKenzie","sequence":"additional","affiliation":[{"name":"Medical Research Council Blood Pressure Group, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Marie","family":"Freel","sequence":"additional","affiliation":[{"name":"Medical Research Council Blood Pressure Group, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fraser","sequence":"additional","affiliation":[{"name":"Medical Research Council Blood Pressure Group, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Davies","sequence":"additional","affiliation":[{"name":"Medical Research Council Blood Pressure Group, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2008,2,21]]},"reference":[{"key":"2019041121432581600_R1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF02158515","article-title":"Constitution of aldosterone, a new mineralocorticoid.","volume":"10","author":"Simpson","year":"1954","journal-title":"Experientia"},{"key":"2019041121432581600_R2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2003.10.004","article-title":"The discovery, isolation and identification of aldosterone: reflections on emerging regulation and function.","volume":"217","author":"Tait","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121432581600_R3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-44-1-1","article-title":"Primary aldosteronism, a new clinical entity.","volume":"44","author":"Conn","year":"1956","journal-title":"Ann Intern Med"},{"key":"2019041121432581600_R4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI113592","article-title":"Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.","volume":"82","author":"Stewart","year":"1988","journal-title":"J Clin Invest"},{"key":"2019041121432581600_R5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated.","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"2019041121432581600_R6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/molehr\/gag091","article-title":"Characterization of human trophoblast as a mineralocorticoid target tissue.","volume":"9","author":"Driver","year":"2003","journal-title":"Mol Hum Reprod"},{"key":"2019041121432581600_R7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2019041121432581600_R8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome.","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121432581600_R9","author":"Orth","year":"1992"},{"key":"2019041121432581600_R10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/er.2003-0030","article-title":"Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.","volume":"25","author":"Payne","year":"2004","journal-title":"Endocr Rev"},{"key":"2019041121432581600_R11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.physiol.63.1.193","article-title":"StAR protein and the regulation of steroid hormone biosynthesis.","volume":"63","author":"Stocco","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"2019041121432581600_R12","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1126\/science.7892608","article-title":"Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis.","volume":"267","author":"Lin","year":"1995","journal-title":"Science"},{"key":"2019041121432581600_R13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01283159","article-title":"Steroidogenic electron transport in adrenal cortex mitochondria.","volume":"45","author":"Lambeth","year":"1982","journal-title":"Mol Cell Biochem"},{"key":"2019041121432581600_R14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-0760(01)00068-1","article-title":"Reflections on sterol sidechain cleavage process catalyzed by cytochrome P450(scc).","volume":"78","author":"Lieberman","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121432581600_R15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/1043-2760(93)90117-W","article-title":"The 3\u03b2-hydroxysteroid dehydrogenase gene family of enzymes.","volume":"4","author":"Mason","year":"1993","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121432581600_R16","doi-asserted-by":"crossref","first-page":"19659","DOI":"10.1016\/S0021-9258(19)36567-6","article-title":"Structure and tissue-specific expression of a novel member of the rat 3\u03b2-hydroxysteroid dehydrogenase\/\u03b4 5-\u03b4 4 isomerase (3\u03b2-HSD) family. The exclusive 3\u03b2-HSD gene expression in the skin.","volume":"268","author":"Simard","year":"1993","journal-title":"J Biol Chem"},{"key":"2019041121432581600_R17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000132878","article-title":"Assignment of the human 3\u03b2-hydroxysteroid dehydrogenase gene to the p13 band of chromosome 1.","volume":"52","author":"Berube","year":"1989","journal-title":"Cytogen Cell Genetics"},{"key":"2019041121432581600_R18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/dna.1991.10.701","article-title":"Structure of the human type II 3\u03b2-hydroxysteroid dehydrogenase\/5,4 isomerase (3\u03b2HSD) gene: adrenal and gonadal specificity.","volume":"10","author":"Lachance","year":"1991","journal-title":"DNA Cell Biology"},{"key":"2019041121432581600_R19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1677\/joe.0.1190191","article-title":"Relationship between zonal distribution of microsomal cytochrome P-450s (P-450(17)\u03b1,lyase and P-450C21) and steroidogenic activities in guinea-pig adrenal cortex.","volume":"119","author":"Shinzawa","year":"1988","journal-title":"J Endocrinol"},{"key":"2019041121432581600_R20","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1073\/pnas.83.14.5111","article-title":"Structure of human steroid 21-hydroxylase genes.","volume":"83","author":"White","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121432581600_R21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/07435809509030460","article-title":"Cloning of CYP11B1 and CYP11B2 from normal human adrenal and their functional expression in COS-7 and V79 Chinese hamster cells.","volume":"21","author":"Denner","year":"1995","journal-title":"Endocr Res"},{"key":"2019041121432581600_R22","doi-asserted-by":"crossref","first-page":"20961","DOI":"10.1016\/S0021-9258(19)30030-4","article-title":"Characterization of two genes encoding human steroid 11\u03b2-hydroxylase (P-450(11) \u03b2).","volume":"264","author":"Mornet","year":"1989","journal-title":"J Biol Chem"},{"key":"2019041121432581600_R23","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1073\/pnas.84.20.7193","article-title":"Cloning of cDNA encoding steroid 11 \u03b2-hydroxylase (P450c11).","volume":"84","author":"Chua","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121432581600_R24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0888-7543(91)90491-V","article-title":"A hybrid cell mapping panel for regional localisation of probes to human chromosome 8.","volume":"10","author":"Wagner","year":"1991","journal-title":"Genomics"},{"key":"2019041121432581600_R25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0303-7207(95)03653-O","article-title":"Cloning and expression of the rat adrenal cytochrome P-450 11B3 (CYP11B3) enzyme cDNA: preferential 18-hydroxylation over 11 \u03b2-hydroxylation of DOC.","volume":"114","author":"Zhou","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121432581600_R26","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1074\/jbc.270.4.1643","article-title":"P450c11B3 mRNA, transcribed from a third P450c11 gene, is expressed in a tissue-specific, developmentally, and hormonally regulated fashion in the rodent adrenal and encodes a protein with both 11-hydroxylase and 18-hydroxylase activities.","volume":"270","author":"Mellon","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041121432581600_R27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.ph.50.030188.002205","article-title":"Regulation of aldosterone secretion.","volume":"50","author":"Quinn","year":"1988","journal-title":"Annu Rev Physiol"},{"key":"2019041121432581600_R28","first-page":"1","article-title":"Regulation of aldosterone biosynthesis. Physiological and clinical aspects.","volume":"29","author":"Muller","year":"1987","journal-title":"Monogr Endocrinol"},{"key":"2019041121432581600_R29","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/en.2003-0150","article-title":"Minireview: overview of the renin-angiotensin system\u2013an endocrine and paracrine system.","volume":"144","author":"Lavoie","year":"2003","journal-title":"Endocrinology"},{"key":"2019041121432581600_R30","first-page":"253","author":"Samani","year":"1994"},{"key":"2019041121432581600_R31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3317\/jraas.2002.043","article-title":"Local renin-angiotensin systems and their interactions with extra-adrenal corticosteroid production.","volume":"3","author":"MacKenzie","year":"2002","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2019041121432581600_R32","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1210\/en.2004-1674","article-title":"Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells.","volume":"146","author":"Sugiyama","year":"2005","journal-title":"Endocrinology"},{"key":"2019041121432581600_R33","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"2019041121432581600_R34","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase.","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041121432581600_R35","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas.","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121432581600_R36","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/HYPERTENSIONAHA.106.076216","article-title":"Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure?","volume":"50","author":"Chappell","year":"2007","journal-title":"Hypertension"},{"key":"2019041121432581600_R37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/FJC.0b013e3180986219","article-title":"ACE2: a new target for cardiovascular disease therapeutics.","volume":"50","author":"Raizada","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"2019041121432581600_R38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways.","volume":"84","author":"Spa\u0308t","year":"2004","journal-title":"Physiol Rev"},{"key":"2019041121432581600_R39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mce.2003.10.011","article-title":"The regulation of aldosterone synthase expression.","volume":"217","author":"Bassett","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121432581600_R40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1081\/ERC-200043715","article-title":"A role for the NGFI-B family in adrenal zonation and adrenocortical disease.","volume":"30","author":"Bassett","year":"2004","journal-title":"Endocr Res"},{"key":"2019041121432581600_R41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2003.10.046","article-title":"Glomerulosa cell\u2013a unique sensor of extracellular K+ concentration.","volume":"217","author":"Spa\u0308t","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121432581600_R42","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/mend.11.5.9920","article-title":"Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements.","volume":"11","author":"Clyne","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2019041121432581600_R43","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1210\/jcem-71-6-1616","article-title":"Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and\/or frequency modulation of underlying pituitary secretory bursts.","volume":"71","author":"Veldhuis","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R44","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1016\/S0021-9258(18)50666-9","article-title":"Adrenocorticotropin action in isolated adrenal cells. The intermediate role of cyclic AMP in stimulation of corticosterone synthesis.","volume":"254","author":"Sala","year":"1979","journal-title":"J Biol Chem"},{"key":"2019041121432581600_R45","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1126\/science.1325670","article-title":"The cloning of a family of genes that encode the melanocortin receptors.","volume":"257","author":"Mountjoy","year":"1992","journal-title":"Science"},{"key":"2019041121432581600_R46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1677\/joe.0.1410285","article-title":"Protein kinase C signal transduction pathway in ACTH-induced growth effect of rat adrenocortical cells in primary culture.","volume":"141","author":"Arola","year":"1994","journal-title":"J Endocrinol"},{"key":"2019041121432581600_R47","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/endo.137.7.8770885","article-title":"15-lipoxygenase metabolite(s) of arachidonic acid mediates adrenocorticotropin action in bovine adrenal steroidogenesis.","volume":"137","author":"Yamazaki","year":"1996","journal-title":"Endocrinology"},{"key":"2019041121432581600_R48","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1210\/endo.139.12.6338","article-title":"Calcium ion as a second messenger for o-nitrophenylsulfenyl-adrenocorticotropin (NPS-ACTH) and ACTH in bovine adrenal steroidogenesis.","volume":"139","author":"Yamazaki","year":"1998","journal-title":"Endocrinology"},{"key":"2019041121432581600_R49","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/07435809609043755","article-title":"Mechanisms of ACTH(cAMP)-dependent transcription of adrenal steroid hydroxylases.","volume":"22","author":"Waterman","year":"1996","journal-title":"Endocr Res"},{"key":"2019041121432581600_R50","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/eje.0.1350739","article-title":"The adrenal gland and ACTH.","volume":"135","author":"Bornstein","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"2019041121432581600_R51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jemt.10331","article-title":"Adrenocortical zonation and ACTH.","volume":"61","author":"Vinson","year":"2003","journal-title":"Microsc Res Tech"},{"key":"2019041121432581600_R52","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1677\/joe.0.1390451","article-title":"Role of adenylate cyclase-cyclic AMP-dependent signal transduction in the ACTH-induced biphasic growth effect of rat adrenocortical cells in primary culture.","volume":"139","author":"Arola","year":"1993","journal-title":"J Endocrinol"},{"key":"2019041121432581600_R53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1530\/acta.0.0950198","article-title":"The effect of chronic low-dose infusion of ACTH (1-24) on renin, renin- substrate, aldosterone and other corticosteroids in sodium replete and deplete man.","volume":"95","author":"Fuchs-Hammoser","year":"1980","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041121432581600_R54","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1210\/endo.132.6.8389287","article-title":"Modulation of aldosterone synthase messenger ribonucleic acid levels by dietary sodium and potassium and by adrenocorticotropin.","volume":"132","author":"Holland","year":"1993","journal-title":"Endocrinology"},{"key":"2019041121432581600_R55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/07435809609043729","article-title":"Regulation of adrenal steroidogenesis during chronic stress.","volume":"22","author":"Aguilera","year":"1996","journal-title":"Endocr Res"},{"key":"2019041121432581600_R56","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1016\/S0021-9258(20)64320-4","article-title":"ACTH-induced inhibition of the action of angiotensin II in bovine zona glomerulosa cells. A modulatory effect of cyclic AMP on the angiotensin II receptor.","volume":"266","author":"Yoshida","year":"1991","journal-title":"J Biol Chem"},{"key":"2019041121432581600_R57","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1210\/endo.134.6.8194473","article-title":"Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells.","volume":"134","author":"Bird","year":"1994","journal-title":"Endocrinology"},{"key":"2019041121432581600_R58","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1210\/endo-122-5-2012","article-title":"Dual regulation of 3\u03b2-hydroxysteroid dehydrogenase, 17\u03b1-hydroxylase, and dehydroepiandrosterone sulfotransferase by adenosine 3\u2032,5\u2032-monophosphate and activators of protein kinase C in cultured human adrenocortical cells.","volume":"122","author":"McAllister","year":"1988","journal-title":"Endocrinology"},{"key":"2019041121432581600_R59","first-page":"2171","article-title":"Differential control of 17\u03b1-hydroxylase and 3\u03b2-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells.","volume":"81","author":"Bird","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R60","first-page":"153","article-title":"Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man.","volume":"8","author":"Richards","year":"1986","journal-title":"Clin Exp Hypertens A"},{"key":"2019041121432581600_R61","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1210\/en.2004-0491","article-title":"The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin.","volume":"145","author":"Coll","year":"2004","journal-title":"Endocrinology"},{"key":"2019041121432581600_R62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2265.2006.02709.x","article-title":"Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia.","volume":"66","author":"Lin","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121432581600_R63","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1440-1681.2003.03867.x","article-title":"Extra-adrenal production of corticosteroids.","volume":"30","author":"Davies","year":"2003","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2019041121432581600_R64","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(93)91332-M","article-title":"Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain.","volume":"629","author":"Mellon","year":"1993","journal-title":"Brain Res"},{"key":"2019041121432581600_R65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0169-328X(95)00140-N","article-title":"Messenger RNAs encoding steroidogenic enzymes are expressed in rodent brain.","volume":"34","author":"Stromstedt","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"2019041121432581600_R66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/07435809609043732","article-title":"Corticosteroid synthesis in the central nervous system.","volume":"22","author":"Gomez-Sanchez","year":"1996","journal-title":"Endocr Res"},{"key":"2019041121432581600_R67","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/07435800009048566","article-title":"Corticosteroid production by fetal rat hippocampal neurons.","volume":"26","author":"MacKenzie","year":"2000","journal-title":"Endocr Res"},{"key":"2019041121432581600_R68","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1046\/j.1471-4159.1998.71062231.x","article-title":"Steroidogenic acute regulatory protein (StAR) transcripts constitutively expressed in the adult rat central nervous system: colocalization of StAR, cytochrome P-450SCC (CYP XIA1), and 3\u03b2- hydroxysteroid dehydrogenase in the rat brain.","volume":"71","author":"Furukawa","year":"1998","journal-title":"J Neurochem"},{"key":"2019041121432581600_R69","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/en.2003-0109","article-title":"Regulation of aldosterone synthase gene expression in the rat adrenal gland and central nervous system by sodium and angiotensin II.","volume":"144","author":"Ye","year":"2003","journal-title":"Endocrinology"},{"key":"2019041121432581600_R70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0303-7207(02)00041-2","article-title":"Steroidogenic enzyme gene expression in the human brain.","volume":"190","author":"Yu","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121432581600_R71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2005.10.024","article-title":"Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues.","volume":"248","author":"Sharma","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121432581600_R72","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.HYP.25.2.170","article-title":"Production of aldosterone in isolated rat blood vessels.","volume":"25","author":"Takeda","year":"1995","journal-title":"Hypertension"},{"key":"2019041121432581600_R73","first-page":"2797","article-title":"Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin.","volume":"81","author":"Takeda","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R74","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1210\/en.2004-0081","article-title":"Do human vascular endothelial cells produce aldosterone?","volume":"145","author":"Ahmad","year":"2004","journal-title":"Endocrinology"},{"key":"2019041121432581600_R75","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.273.9.4883","article-title":"Myocardial production of aldosterone and corticosterone in the rat.","volume":"237","author":"Silvestre","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041121432581600_R76","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.HYP.36.4.495","article-title":"Cardiac aldosterone production in genetically hypertensive rats.","volume":"36","author":"Takeda","year":"2000","journal-title":"Hypertension"},{"key":"2019041121432581600_R77","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0303-7207(00)00258-6","article-title":"Tissue-specific corticosteroidogenesis in the rat.","volume":"165","author":"Rudolph","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121432581600_R78","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1210\/en.2005-0370","article-title":"The aldosterone synthase (CYP11B2) and 11\u03b2-hydroxylase (CYP11B1) genes are not expressed in the rat heart.","volume":"146","author":"Ye","year":"2005","journal-title":"Endocrinology"},{"key":"2019041121432581600_R79","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1210\/en.2004-0295","article-title":"Origin of aldosterone in the rat heart.","volume":"145","author":"Gomez-Sanchez","year":"2004","journal-title":"Endocrinology"},{"key":"2019041121432581600_R80","first-page":"2519","article-title":"Steroidogenic enzyme gene expression in the human heart.","volume":"85","author":"Kayes-Wandover","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R81","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jsbmb.2003.07.006","article-title":"Profiling transcript levels for steroidogenic enzymes in fetal tissues.","volume":"87","author":"Pezzi","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121432581600_R82","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1210\/jcem.86.11.7925","article-title":"Cardiac steroidogenesis in the normal and failing heart.","volume":"86","author":"Young","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R83","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/01.CIR.103.1.72","article-title":"Aldosterone production is activated in failing ventricle in humans.","volume":"103","author":"Mizuno","year":"2001","journal-title":"Circulation"},{"key":"2019041121432581600_R84","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/01.HYP.0000015905.27598.E9","article-title":"Aldosterone is produced from ventricles in patients with essential hypertension.","volume":"39","author":"Yamamoto","year":"2002","journal-title":"Hypertension"},{"key":"2019041121432581600_R85","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0002-9149(00)01006-7","article-title":"Transcardiac extraction of circulating endothelin-1 across the failing heart.","volume":"86","author":"Tsutamoto","year":"2002","journal-title":"Am J Cardiol"},{"key":"2019041121432581600_R86","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2003-030373","article-title":"Aldosterone: direct effects on and production by the heart.","volume":"88","author":"White","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R87"},{"key":"2019041121432581600_R88","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1210\/me.2005-0247","article-title":"The evolution of mineralocorticoid receptors.","volume":"20","author":"Hu","year":"2006","journal-title":"Mol Endocrinol"},{"key":"2019041121432581600_R89","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"2019041121432581600_R90","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mce.2003.10.021","article-title":"Mineralocorticoid receptor binding, structure and function.","volume":"217","author":"Rogerson","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121432581600_R91","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1749-6632.2003.tb07219.x","article-title":"FXYD proteins: new tissue-and isoform-specific regulators of Na, K-ATPase.","volume":"986","author":"Geering","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"2019041121432581600_R92","doi-asserted-by":"crossref","first-page":"F559","DOI":"10.1152\/ajprenal.00320.2001","article-title":"New ideas about aldosterone signaling in epithelia","volume":"282","author":"Stockand","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041121432581600_R93","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1152\/ajpcell.1998.274.5.C1373","article-title":"Hormonal regulation of ENaCs: insulin and aldosterone.","volume":"274","author":"Blazer-Yost","year":"1998","journal-title":"Am J Physiol"},{"key":"2019041121432581600_R94","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1152\/ajpcell.1999.277.3.C531","article-title":"Phosphoinositide 3-kinase is required for aldosterone-regulated sodium reabsorption.","volume":"277","author":"Blazer-Yost","year":"1999","journal-title":"Am J Physiol"},{"key":"2019041121432581600_R95","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1152\/ajpheart.00421.2002","article-title":"Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1\/2 signaling.","volume":"284","author":"Stockand","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019041121432581600_R96","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1172\/JCI31538","article-title":"Salt, sodium channels, and SGK1.","volume":"117","author":"Pearce","year":"2007","journal-title":"J Clin Invest"},{"key":"2019041121432581600_R97","doi-asserted-by":"crossref","first-page":"38134","DOI":"10.1074\/jbc.M403260200","article-title":"A novel pathway of epithelial sodium channel activation involves a serum- and glucocorticoid-inducible kinase consensus motif in the C terminus of the channel\u2019s \u03b1-subunit.","volume":"279","author":"Diakov","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041121432581600_R98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000070245","article-title":"SGK1 regulation of epithelial sodium transport.","volume":"13","author":"Pearce","year":"2003","journal-title":"Cell Physiol Biochem"},{"key":"2019041121432581600_R99","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1074\/jbc.C100623200","article-title":"Serum and glucocorticoid-regulated kinase modulate Nedd4\u20132 mediated inhibition of the epithelial Na+ channel.","volume":"277","author":"Synder","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041121432581600_R100","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1172\/JCI29850","article-title":"Aldosterone-induced Sgk1 relieves Dot1a-Af9-mediated transcriptional repression of epithelial Na+ channel \u03b1.","volume":"117","author":"Zhang","year":"2007","journal-title":"J Clin Invest"},{"key":"2019041121432581600_R101","doi-asserted-by":"crossref","first-page":"F714","DOI":"10.1152\/ajprenal.00061.2006","article-title":"Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ","volume":"291","author":"Bhalla","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"2019041121432581600_R102","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1210\/endo.137.12.8940344","article-title":"Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies.","volume":"137","author":"Funder","year":"1996","journal-title":"Endocrinology"},{"key":"2019041121432581600_R103","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1043-2760(00)00270-8","article-title":"Aldosterone and the heart.","volume":"11","author":"Young","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121432581600_R104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","article-title":"Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.","volume":"93","author":"Qin","year":"2003","journal-title":"Circ Res"},{"key":"2019041121432581600_R105","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/endo-118-2-819","article-title":"Intracerebroventricular infusion of aldosterone induces hypertension in rats.","volume":"118","author":"Gomez-Sanchez","year":"1986","journal-title":"Endocrinology"},{"key":"2019041121432581600_R106","first-page":"482","article-title":"Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension.","volume":"258","author":"Gomez-Sanchez","year":"1990","journal-title":"Am J Physiol"},{"key":"2019041121432581600_R107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(98)00161-2","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain.","volume":"61","author":"Robson","year":"1998","journal-title":"Mol Brain Res"},{"key":"2019041121432581600_R108","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/frne.1996.0143","article-title":"11\u03b2-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?","volume":"18","author":"Seckl","year":"1997","journal-title":"Front Neuroendocrinol"},{"key":"2019041121432581600_R109","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cne.20808","article-title":"Aldosterone-sensitive neurons in the rat central nervous system.","volume":"494","author":"Geerling","year":"2006","journal-title":"J Comp Neurol"},{"key":"2019041121432581600_R110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/exnr.1993.1059","article-title":"Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system.","volume":"120","author":"Broadwell","year":"1993","journal-title":"Exp Neurol"},{"key":"2019041121432581600_R111","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1210\/jc.2005-1718","article-title":"Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy.","volume":"91","author":"Takebayashi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R112","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-2005-870240","article-title":"Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes.","volume":"37","author":"Kraus","year":"2005","journal-title":"Horm Metab Res"},{"key":"2019041121432581600_R113","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019041121432581600_R114","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralocorticoid receptor affects AP-1 and nuclear factor-\u03baB activation in angiotensin II-induced cardiac injury.","volume":"37","author":"Fiebeler","year":"2001","journal-title":"Hypertension"},{"key":"2019041121432581600_R115","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/01.hjh.0000170379.08214.5a","article-title":"Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: role of the NF\u03baB\/I\u03baB system.","volume":"23","author":"Sanz-Rosa","year":"2005","journal-title":"J Hypertens"},{"key":"2019041121432581600_R116","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase.","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J"},{"key":"2019041121432581600_R117","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mce.2003.10.013","article-title":"Aldosterone synthase deficiency and related disorders.","volume":"217","author":"White","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121432581600_R118","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.1073\/pnas.95.16.9424","article-title":"Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism.","volume":"95","author":"Berger","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121432581600_R119","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/01.HYP.0000249902.09036.e7","article-title":"Disturbed homeostasis in sodium-restricted mice heterozygous and homozygous for aldosterone synthase gene disruption.","volume":"48","author":"Makhanova","year":"2006","journal-title":"Hypertension"},{"key":"2019041121432581600_R120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons.","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"key":"2019041121432581600_R121","first-page":"OC24","article-title":"Acute aldosterone responses to ACTH predict both cortisol responses and blood pressure","volume":"13","author":"Reynolds","year":"2007","journal-title":"Endocr Abstracts"},{"key":"2019041121432581600_R122","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R123","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2019041121432581600_R124","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","article-title":"Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature.","volume":"31","author":"Montori","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041121432581600_R125","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension.","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"2019041121432581600_R126","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Minireview: primary aldosteronism\u2013changing concepts in diagnosis and treatment.","volume":"144","author":"Young Jr","year":"2003","journal-title":"Endocrinology"},{"key":"2019041121432581600_R127","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(81)90424-4","article-title":"The myth of idiopathic hyperaldosteronism.","volume":"2","author":"Padfield","year":"1981","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2019041121432581600_R128","first-page":"99","article-title":"Renin subgroups in essential hypertension","volume":"32","author":"Brunner","year":"1973","journal-title":"Further analysis of their pathophysiological and epidemiological characteristics. Circ Res"},{"key":"2019041121432581600_R129","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0140-6736(75)91559-7","article-title":"Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?","volume":"1","author":"Padfield","year":"1975","journal-title":"Lancet"},{"key":"2019041121432581600_R130","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0022-4731(75)90067-9","article-title":"Inter-relationships between plasma angiotensin II, arterial pressure, aldosterone and exchangeable sodium in normotensive and hypertensive man.","volume":"6","author":"Beevers","year":"1975","journal-title":"J Steroid Biochem"},{"key":"2019041121432581600_R131","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2019041121432581600_R132","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0002-9149(93)90240-D","article-title":"Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension.","volume":"71","author":"Duprez","year":"1993","journal-title":"Am J Cardiol"},{"key":"2019041121432581600_R133","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/CIRCULATIONAHA.106.634626","article-title":"High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction.","volume":"114","author":"Beygui","year":"2006","journal-title":"Circulation"},{"key":"2019041121432581600_R134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9149(01)01878-1","article-title":"The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data.","volume":"88","author":"Dzau","year":"2001","journal-title":"Am J Cardiol"},{"key":"2019041121432581600_R135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9149(90)90475-G","article-title":"Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group.","volume":"66","author":"Swedberg","year":"1990","journal-title":"Am J Cardiol"},{"key":"2019041121432581600_R136","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/euhj.1998.1093","article-title":"Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.","volume":"19","author":"Vantrimpont","year":"1998","journal-title":"Eur Heart J"},{"key":"2019041121432581600_R137","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2019041121432581600_R138","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.100.10.1056","article-title":"Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.","volume":"100","author":"McKelvie","year":"1999","journal-title":"Circulation"},{"key":"2019041121432581600_R139","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension.","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ Res"},{"key":"2019041121432581600_R140","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"2019041121432581600_R141","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"2019041121432581600_R142","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1210\/en.2004-0005","article-title":"Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone\/salt-treated rats.","volume":"145","author":"Young","year":"2004","journal-title":"Endocrinology"},{"key":"2019041121432581600_R143","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.","volume":"120","author":"Brilla","year":"1992","journal-title":"J Lab Clin Med"},{"key":"2019041121432581600_R144","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.mce.2003.10.054","article-title":"Aldosterone, mineralocorticoid receptors and vascular inflammation.","volume":"217","author":"Funder","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121432581600_R145","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.107.091058","article-title":"Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.","volume":"50","author":"Nagase","year":"2007","journal-title":"Hypertension"},{"key":"2019041121432581600_R146","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/HYPERTENSIONAHA.107.098012","article-title":"Mineralocorticoid receptor activation and oxidative stress.","volume":"50","author":"Funder","year":"2007","journal-title":"Hypertension"},{"key":"2019041121432581600_R147","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","article-title":"Pathophysiological effects of aldosterone in cardiovascular tissues.","volume":"12","author":"Rocha","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121432581600_R148","first-page":"39","article-title":"Steroids, hypertension and cardiac fibrosis.","volume":"4","author":"Funder","year":"1995","journal-title":"Blood Press"},{"key":"2019041121432581600_R149","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.HYP.24.1.30","article-title":"Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension.","volume":"24","author":"Robert","year":"1994","journal-title":"Hypertension"},{"key":"2019041121432581600_R150","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1210\/en.2003-0039","article-title":"Mineralocorticoid action and sodium-hydrogen exchange: studies in experimental cardiac fibrosis.","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"2019041121432581600_R151","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"2019041121432581600_R152","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress.","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"2019041121432581600_R153","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/01.RES.0000244092.95152.86","article-title":"Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure.","volume":"99","author":"Kang","year":"2006","journal-title":"Circ Res"},{"key":"2019041121432581600_R154","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.33.1.232","article-title":"Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats.","volume":"33","author":"Rocha","year":"1999","journal-title":"Hypertension"},{"key":"2019041121432581600_R155","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","article-title":"Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.","volume":"1","author":"Epstein","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019041121432581600_R156","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"2019041121432581600_R157","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","article-title":"Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism.","volume":"31","author":"Litchfield","year":"1998","journal-title":"Hypertension"},{"key":"2019041121432581600_R158","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/hrt.2003.017368","article-title":"Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment.","volume":"90","author":"Macdonald","year":"2004","journal-title":"Heart"},{"key":"2019041121432581600_R159","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.mce.2003.10.024","article-title":"Aldosterone-induced vasculopathy.","volume":"217","author":"Struthers","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121432581600_R160","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.amjhyper.2007.03.012","article-title":"Adiponectin and insulin sensitivity in primary aldosteronism.","volume":"20","author":"Fallo","year":"2007","journal-title":"Am J Hypertens"},{"key":"2019041121432581600_R161","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/dc07-0525","article-title":"Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients.","volume":"30","author":"Colussi","year":"2007","journal-title":"Diabetes Care"},{"key":"2019041121432581600_R162","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000248135.97380.76","article-title":"Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.","volume":"48","author":"Luther","year":"2006","journal-title":"Hypertension"},{"key":"2019041121432581600_R163","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample.","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"2019041121432581600_R164"},{"key":"2019041121432581600_R165","first-page":"527","article-title":"The influence of potassium on the renal vasculature and the adrenal gland, and their responsiveness to angiotensin II in normal man.","volume":"49","author":"Hollenberg","year":"1975","journal-title":"Clin Sci Mol Med"},{"key":"2019041121432581600_R166","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.amjhyper.2004.12.005","article-title":"Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study.","volume":"18","author":"Kathiresan","year":"2005","journal-title":"Am J Hypertens"},{"key":"2019041121432581600_R167","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ki.1975.120","article-title":"Effect of aging on plasma renin and aldosterone in normal man.","volume":"8","author":"Weidmann","year":"1975","journal-title":"Kidney Int"},{"key":"2019041121432581600_R168","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ki.1978.171","article-title":"Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension.","volume":"14","author":"Weidmann","year":"1978","journal-title":"Kidney Int"},{"key":"2019041121432581600_R169","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1210\/jc.2003-032179","article-title":"Aldosterone to renin ratio in a primary care setting: the Bussolengo study.","volume":"89","author":"Olivieri","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R170","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1210\/jcem-62-2-384","article-title":"Effect of age on the renin-angiotensin-aldosterone system in normal subjects: simultaneous measurement of active and inactive renin, renin substrate, and aldosterone in plasma.","volume":"62","author":"Tsunoda","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R171","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0022-4731(76)90016-9","article-title":"Studies on the control of aldosterone secretion in man.","volume":"7","author":"James","year":"1976","journal-title":"J Steroid Biochem"},{"key":"2019041121432581600_R172","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.CIR.60.3.697","article-title":"Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men.","volume":"60","author":"Luft","year":"1979","journal-title":"Circulation"},{"key":"2019041121432581600_R173","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF01476959","article-title":"Interrelations between age and plasma renin, aldosterone and cortisol, urinary catecholamines, and the body sodium\/volume state in normal man.","volume":"55","author":"Weidmann","year":"1977","journal-title":"Klin Wochenschr"},{"key":"2019041121432581600_R174","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/07435809809032689","article-title":"Aldosterone in obesity.","volume":"24","author":"Goodfriend","year":"1998","journal-title":"Endocr Res"},{"key":"2019041121432581600_R175","first-page":"4132","article-title":"Familial pattern of corticosteroids and their metabolism in adult human subjects\u2014the Scottish adult twin study.","volume":"84","author":"Inglis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R176","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.HYP.36.1.7","article-title":"Genetic determinants of hypertension: identification of candidate phenotypes.","volume":"36","author":"Kotchen","year":"2000","journal-title":"Hypertension"},{"key":"2019041121432581600_R177","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1210\/jc.2006-1481","article-title":"Association between aldosterone production and variation in the 11\u03b2-hydroxylase (CYP11B1) gene.","volume":"91","author":"Imrie","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R178","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/237338a0","article-title":"Possible role of 18-hydroxy-deoxycorticosterone in hypertension.","volume":"237","author":"Rapp","year":"1972","journal-title":"Nature"},{"key":"2019041121432581600_R179","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/ng0493-346","article-title":"Linkage of 11\u03b2-hydroxylase mutations with altered steroid biosynthesis and blood pressure in Dahl rat.","volume":"3","author":"Cicila","year":"1993","journal-title":"Nat Genet"},{"key":"2019041121432581600_R180","doi-asserted-by":"crossref","first-page":"16555","DOI":"10.1074\/jbc.270.28.16555","article-title":"Molecular variants in the P450c11AS gene as determinants of aldosterone synthase activity in the Dahl rat model of hypertension.","volume":"270","author":"Cover","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041121432581600_R181","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"key":"2019041121432581600_R182","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/0003-4819-116-10-813","article-title":"Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype.","volume":"116","author":"Rich","year":"1992","journal-title":"Ann Intern Med"},{"key":"2019041121432581600_R183","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11\u03b2-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"2019041121432581600_R184","first-page":"421","article-title":"Disorders of steroid 11\u03b2-hydroxylase isozymes.","volume":"15","author":"White","year":"1994","journal-title":"Endocr Rev"},{"key":"2019041121432581600_R185","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/07435809509030459","article-title":"Haplotype analysis of CYP11B2.","volume":"21","author":"White","year":"1995","journal-title":"Endocr Res"},{"key":"2019041121432581600_R186","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/jme.0.0280125","article-title":"Differential regulation of aldosterone synthase and 11\u03b2-hydroxylase transcription by steroidogenic factor-1.","volume":"28","author":"Bassett","year":"2002","journal-title":"J Mol Endocrinol"},{"key":"2019041121432581600_R187","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.HYP.33.2.703","article-title":"Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2.","volume":"33","author":"Davies","year":"1999","journal-title":"Hypertension"},{"key":"2019041121432581600_R188","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.HYP.32.2.198","article-title":"Structural analysis and evaluation of the aldosterone synthase gene in hypertension.","volume":"32","author":"Brand","year":"1998","journal-title":"Hypertension"},{"key":"2019041121432581600_R189","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.HYP.34.3.423","article-title":"Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population.","volume":"34","author":"Paillard","year":"1999","journal-title":"Hypertension"},{"key":"2019041121432581600_R190","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.HYP.35.3.699","article-title":"Lys173Arg and -344T\/C variants of CYP11B2 in Japanese patients with low-renin hypertension.","volume":"35","author":"Komiya","year":"2000","journal-title":"Hypertension"},{"key":"2019041121432581600_R191","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1210\/jc.2001-012070","article-title":"Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone to renin ratio.","volume":"87","author":"Lim","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R192","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0895-7061(98)00048-X","article-title":"Genetic determination of plasma aldosterone levels in essential hypertension.","volume":"11","author":"Pojoga","year":"1998","journal-title":"Am J Hypertens"},{"key":"2019041121432581600_R193","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1291\/hypres.24.105","article-title":"Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita study.","volume":"24","author":"Tsujita","year":"2001","journal-title":"Hypertens Res"},{"key":"2019041121432581600_R194","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.hjh.0000254372.88488.a9","article-title":"Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis.","volume":"25","author":"Sookoian","year":"2007","journal-title":"J Hypertens"},{"key":"2019041121432581600_R195","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.1141634","article-title":"A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.","volume":"316","author":"Frayling","year":"2007","journal-title":"Science"},{"key":"2019041121432581600_R196","first-page":"321","article-title":"Gene conversion in the CYP11B2 gene encoding P450c11AS is associated with, but does not cause, the syndrome of corticosterone methyloxidase II deficiency.","volume":"81","author":"Fardella","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R197","first-page":"4347","article-title":"Genetic variation in P450c11AS in Chilean patients with low renin hypertension.","volume":"81","author":"Fardella","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R198","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1210\/jc.2005-0299","article-title":"Association of Lys173Arg polymorphism with CYP11B2 expression in normal adrenal glands and aldosterone-producing adenomas.","volume":"90","author":"Tanahashi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R199","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2004-0870","article-title":"Genetic variation at the locus encompassing 11-\u03b2 hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion.","volume":"90","author":"Keavney","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R200","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(00)04223-9","article-title":"Cautions over the current epidemic of primary aldosteronism.","volume":"357","author":"Kaplan","year":"2001","journal-title":"Lancet"},{"key":"2019041121432581600_R201","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.HYP.7.2.204","article-title":"Partial deficiency of adrenal 11\u03b2-hydroxylase\u2014a possible cause of primary hypertension.","volume":"7","author":"Simone","year":"1985","journal-title":"Hypertension"},{"key":"2019041121432581600_R202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2796.1998.00308.x","article-title":"Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males.","volume":"244","author":"Hautanena","year":"1998","journal-title":"J Intern Med"},{"key":"2019041121432581600_R203","first-page":"391","article-title":"Mildly raised corticosterone excretion rates in patients with essential hypertension.","volume":"9","author":"Soro","year":"1995","journal-title":"J Hum Hypertens"},{"key":"2019041121432581600_R204","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1210\/jc.2004-1031","article-title":"CYP11B2-CYP11B1 haplotypes associated with decreased 11\u03b2-hydroxylase activity.","volume":"90","author":"Ganapathipillai","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R205","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1365-2265.2001.01264.x","article-title":"An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects.","volume":"54","author":"Davies","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121432581600_R206","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.HYP.0000249904.93940.7a","article-title":"Polymorphic variation in the 11\u03b2-hydroxylase gene associates with reduced 11-hydroxylase efficiency.","volume":"49","author":"Barr","year":"2007","journal-title":"Hypertension"},{"key":"2019041121432581600_R207","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1530\/eje.0.1390249","article-title":"Mitochondrial regulation of mineralocorticoid biosynthesis by calcium and StAR protein.","volume":"139","author":"Cherradi","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2019041121432581600_R208","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/acta.0.1080091","article-title":"Prolonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity.","volume":"108","author":"Oelkers","year":"1985","journal-title":"Acta Endocrinol"},{"key":"2019041121432581600_R209","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/jcem-27-4-568","article-title":"ACTH stimulation of aldosterone secretion in normal subjects and in patients with chronic adrenocortical insufficiency.","volume":"27","author":"Tucci","year":"1967","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R210","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1530\/acta.0.0940559","article-title":"Biosynthetic ad morphological evidence for inhibition of aldosterone production following administration of ACTH to sheep.","volume":"94","author":"McDougall","year":"1980","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041121432581600_R211","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00004872-198708000-00007","article-title":"Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man.","volume":"5","author":"Connell","year":"1987","journal-title":"J Hypertens"},{"key":"2019041121432581600_R212","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jcem-42-2-355","article-title":"The effect of administered ACTH on aldosterone metabolism and secretion.","volume":"42","author":"Pratt","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R213","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1210\/jcem-40-1-116","article-title":"Plasma aldosterone and renin activity response to ACTH infusion in dexamethasone-suppressed normal and sodium-depleted man.","volume":"40","author":"Kem","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R214","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2265.1995.tb02037.x","article-title":"Responses of plasma adrenocortical steroids to low dose ACTH in normal subjects.","volume":"43","author":"Daidoh","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121432581600_R215","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1172\/JCI104740","article-title":"In vivo and in vitro studies of adrenal secretions in Cushing\u2019s syndrome and primary aldosteronism.","volume":"42","author":"Biglieri","year":"1963","journal-title":"J Clin Invest"},{"key":"2019041121432581600_R216","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/jcem-40-1-125","article-title":"Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man.","volume":"40","author":"Katz","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R217","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jcem-43-1-115","article-title":"Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism.","volume":"43","author":"Schambelan","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121432581600_R218","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0010-4809(74)90029-9","article-title":"Time series analysis of hormonal patterns in human plasma.","volume":"7","author":"Vagnucci","year":"1974","journal-title":"Comput Biomed Res"},{"key":"2019041121432581600_R219","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI111941","article-title":"Plasma immunoreactive \u03b3 melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension.","volume":"76","author":"Griffing","year":"1985","journal-title":"J Clin Invest"},{"key":"2019041121432581600_R220","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1365-2265.2007.02971.x","article-title":"Phenotypic consequences of variation across the aldosterone synthase and 11-\u03b2 hydroxylase locus in a hypertensive cohort: data from the MRC BRIGHT Study.","volume":"67","author":"Freel","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121432581600_R221","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.1966.03110240051022","article-title":"Treatment of hypertension with spironolactone. Double-blind study.","volume":"198","author":"Wolf","year":"1966","journal-title":"JAMA"},{"key":"2019041121432581600_R222","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension.","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"2019041121432581600_R223","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.107.690396","article-title":"The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.","volume":"116","author":"Hood","year":"2007","journal-title":"Circulation"},{"key":"2019041121432581600_R224","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"2019041121432581600_R225","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats.","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"2019041121432581600_R226","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000077396","article-title":"Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME\/SHR model.","volume":"24","author":"Zhou","year":"2004","journal-title":"Am J Nephrol"},{"key":"2019041121432581600_R227","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1210\/en.2006-0944","article-title":"Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.","volume":"147","author":"Guo","year":"2006","journal-title":"Endocrinology"},{"key":"2019041121432581600_R228","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension.","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens"},{"key":"2019041121432581600_R229","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","article-title":"Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension.","volume":"41","author":"White","year":"2003","journal-title":"Hypertension"},{"key":"2019041121432581600_R230","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2004.01.007","article-title":"Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.","volume":"93","author":"Williams","year":"2004","journal-title":"Am J Cardiol"},{"key":"2019041121432581600_R231","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ahj.2004.12.005","article-title":"Effects of eplerenone versus losartan in patients with low-renin hypertension.","volume":"150","author":"Weinberger","year":"2005","journal-title":"Am Heart J"},{"key":"2019041121432581600_R232","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0735-1097(03)00054-8","article-title":"Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients.","volume":"41","author":"Flack","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2019041121432581600_R233","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"2019041121432581600_R234","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2006.11.032","article-title":"Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension.","volume":"49","author":"Oh","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2019041121432581600_R235","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1517\/14656566.8.5.529","article-title":"Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?","volume":"8","author":"Athyros","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"2019041121432581600_R236","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/01.hjh.0000226205.65442.f2","article-title":"Investigation of aldosterone-synthase inhibition in rats.","volume":"24","author":"Menard","year":"2006","journal-title":"J Hypertens"},{"key":"2019041121432581600_R237","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/j.1552-4604.1993.tb03901.x","article-title":"Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors.","volume":"33","author":"Borghi","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"2019041121432581600_R238","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9149(01)02261-5","article-title":"Relation of aldosterone \u201cescape\u201d despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.","volume":"89","author":"Cicoira","year":"2002","journal-title":"Am J Cardiol"},{"key":"2019041121432581600_R239","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/29\/2\/133\/8862205\/edrv0133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T02:02:19Z","timestamp":1630980139000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/29\/2\/133\/2354980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,21]]},"references-count":239,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,2,21]]},"published-print":{"date-parts":[[2008,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2007-0030","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,21]]}}}